Hospital
Alhambra Hospital Medical Center, LP
Alhambra Hospital Medical Center, LP was paid $6.90M by Medicaid between Jan 2018 and Nov 2024, across 118 billing codes. Its largest line is 0450, Emergency room services — 28% of everything it billed.
33Billing provider infoALHAMBRA HOSPITAL MEDICAL CENTER, LP
ALHAMBRA, CA 91801
ALHAMBRA, CA 91801
33aNPI1477682466assigned 03/05/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.90M
24GClaims175,544
24DCodes billed118
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#206 of 410
Median peer was paid$6.90M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MARSH, LINDA controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43,567 | $1.67M | |
| 2019 | 31,412 | $1.38M | |
| 2020 | 15,670 | $791K | |
| 2021 | 16,932 | $640K | |
| 2022 | 26,862 | $1.18M | |
| 2023 | 20,950 | $679K | |
| 2024incomplete | 20,151 | $558K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 28% | 26,500 | 23,371 | $1.92M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 5.5% | 1,829 | 1,791 | $376K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.4% | 4,251 | 4,022 | $370K |
| 96375 | Therapeutic injection; each additional sequential IV push | 5.1% | 3,803 | 3,551 | $352K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.7% | 2,165 | 2,100 | $324K |
| 80053 | Comprehensive metabolic panel | 3.9% | 9,482 | 8,793 | $267K |
| J3490 | Unclassified drugs | 3.1% | 5,784 | 4,842 | $213K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.9% | 4,046 | 3,646 | $198K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 2.7% | 1,914 | 1,809 | $184K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.5% | 3,514 | 3,225 | $175K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.3% | 1,867 | 1,798 | $160K |
| 0270 | 2.2% | 2,866 | 2,427 | $150K |
106 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.1% | 5,114 | $144K |
| 71045 | Radiologic examination, chest; single view | 2.1% | 6,057 | $142K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.9% | 3,894 | $132K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 10,867 | $127K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 1.7% | 1,265 | $114K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.4% | 2,899 | $99K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.3% | 312 | $89K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.2% | 1,173 | $85K |
| 84484 | 1.2% | 4,212 | $84K | |
| 99199 | Unlisted special service, procedure or report | 1.1% | 1,657 | $76K |
| 83690 | <1% | 4,344 | $69K | |
| Z7502 | <1% | 1,737 | $63K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,699 | $52K |
| 0301 | <1% | 633 | $52K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 994 | $51K |
| 81000 | <1% | 5,861 | $51K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 370 | $50K |
| 85730 | <1% | 4,567 | $45K | |
| 81025 | <1% | 3,643 | $44K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,837 | $42K |
| 87040 | <1% | 1,235 | $38K | |
| 85610 | <1% | 4,628 | $37K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 682 | $35K |
| 83880 | <1% | 1,202 | $35K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 430 | $33K |
| 87428 | <1% | 262 | $29K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 289 | $28K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,803 | $25K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,236 | $24K |
| 83605 | <1% | 1,420 | $21K | |
| 82150 | <1% | 1,543 | $18K | |
| 80076 | <1% | 800 | $18K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 486 | $18K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,607 | $16K |
| 84703 | <1% | 872 | $15K | |
| 0360 | <1% | 269 | $15K | |
| 99283 | Emergency room visit (moderate) | <1% | 349 | $15K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,110 | $15K |
| 0272 | <1% | 2,514 | $15K | |
| 0710 | <1% | 340 | $14K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,018 | $14K |
| 0250 | <1% | 2,049 | $13K | |
| 81002 | <1% | 2,386 | $12K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,289 | $9K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 554 | $8K |
| 90715 | <1% | 154 | $7K | |
| 87186 | <1% | 306 | $7K | |
| 82550 | <1% | 697 | $6K | |
| 73562 | <1% | 108 | $6K | |
| 87077 | <1% | 290 | $4K | |
| 85379 | <1% | 291 | $4K | |
| 83735 | <1% | 670 | $4K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 711 | $4K |
| Z7610 | <1% | 314 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 86 | $3K |
| 73610 | <1% | 98 | $3K | |
| 82948 | <1% | 559 | $3K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 200 | $2K |
| 73630 | <1% | 53 | $2K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 219 | $2K |
| 0637 | <1% | 316 | $2K | |
| 73030 | <1% | 53 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 225 | $1K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 354 | $1K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 69 | $1K |
| 72110 | <1% | 45 | $1K | |
| 73130 | <1% | 53 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 59 | $1K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 189 | $909.78 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 58 | $775.21 |
| 87070 | <1% | 53 | $667.91 | |
| 99070 | <1% | 179 | $523.07 | |
| 99284 | Emergency room visit (serious) | <1% | 40 | $430.88 |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 56 | $383.78 |
| 84702 | <1% | 56 | $383.26 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 98 | $358.97 |
| 0300 | <1% | 15 | $304.98 | |
| 71010 | <1% | 23 | $293.29 | |
| 86901 | <1% | 136 | $276.54 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 49 | $252.31 |
| 73080 | <1% | 12 | $217.06 | |
| 94760 | <1% | 37 | $191.87 | |
| 81015 | <1% | 121 | $162.55 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 64 | $130.50 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 76 | $121.24 |
| 86900 | <1% | 81 | $120.48 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 19 | $107.12 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 16 | $106.82 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 15 | $104.50 |
| 87280 | <1% | 18 | $99.59 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 12 | $97.91 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 12 | $95.48 |
| 86850 | <1% | 12 | $88.56 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 14 | $83.47 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 62 | $82.66 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 13 | $56.31 |
| 84439 | <1% | 12 | $44.31 | |
| A0425 | Ground mileage, per statute mile | <1% | 183 | $16.76 |
| E0601 | Continuous positive airway pressure (cpap) device | 0% | 70 | $0.00 |
| A0429 | Emergency ambulance ride, basic life support | 0% | 17 | $0.00 |
| A0424 | Extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged); (requires medical review) | 0% | 54 | $0.00 |
| E0562 | Humidifier, heated, used with positive airway pressure device | 0% | 142 | $0.00 |
| A0398 | Als routine disposable supplies | 0% | 26 | $0.00 |
| 0324 | 0% | 16 | $0.00 | |
| E0570 | Nebulizer, with compressor | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARSH, LINDA (CHIEF FINANCIAL OFFICIER)
| Provider | Location | Paid |
|---|---|---|
| Ahmc Garfield Medical Center LP | Monterey Park, CA | $17.83M |
| Ahmc Whittier Hospital Medical | Whittier, CA | $15.12M |
| Ahmc Anaheim Regional Medical | Anaheim, CA | $14.21M |
| Ahmc Monterey Park Hospital LP | Monterey Park, CA | $10.85M |
| Ahmc Greater El Monte Community | South El Monte, CA | $9.17M |
| Ahmc San Gabriel Valley Medical | San Gabriel, CA | $6.96M |
| Ahmc Seton Medical Center LLC | Daly City, CA | $5.21M |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $1.57M |
| Ahmc San Gabriel Valley Medical | San Gabriel, CA | $249K |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $176K |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $34K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.